Let gene therapy benefit humans

OBiO has always been adhering to the objective of "integrate your and my resources, serve for life science", under the business model of "Multi-cooperation + research service + industrial support", providing overall solution of viral based gene therapy CRO services, and CDMO/CMO services for gene drug production, for the domestic universities and scientific research institutions, medical institutions and pharmaceutical companies.

With the strategy of “build a platform, develop a number of drugs, provide services for a group of customers, promote gene therapy industry”, OBiO has collaborated with GE Healthcare since March 29th, 2017, to set up the first domestic GMP viral production workshop in China (>5,000 ㎡), for CRO/CDMO/CMO services of viral drugs. Meanwhile, OBiO also focus on incubating gene therapy drugs for cancer therapy. By now, OBiO has got 3 candidate ADC......